McKesson Corporation ($MCK) Stock Forecast: Down 7.5% Today

What is McKesson Corporation?

McKesson (MCK) is a healthcare company specializing in pharmaceuticals and medical supplies with a market capitalization of $87.28 billion. It has demonstrated strong performance over the past 5 years.

Why is McKesson Corporation going down?

MCK stock is down 7.5% on Aug 7, 2025 16:56

• Q1 earnings surpassed expectations and the FY26 EPS outlook was raised, but McKesson's stock faced a downward trend.
• Investor concerns were influenced by a decreasing gross margin and uncertainties regarding the company's spin-off plans, contributing to the decline in stock value.
• Despite strong prescription volume growth driven by GLP-1 demand, it may not have fully countered the impact of reduced margins on overall profitability.
• The market reaction, including a sell-off, seemed to indicate that investors were anticipating even more robust performance from McKesson despite the positive earnings outcomes.

MCK Price Chart

MCK Technical Analysis

MCK News

MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View

McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.

https://www.zacks.com/stock/news/2678116/mck-stock-down-despite-q1-earnings-beat-raised-26-eps-view

McKesson ( MCK ) Surpasses Q1 Earnings and Revenue Estimates

McKesson (MCK) delivered earnings and revenue surprises of +0.36% and +1.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2674980/mckesson-mck-surpasses-q1-earnings-and-revenue-estimates

Will GLP-1 Demand Drive MCK's Top Line This Earnings Season?

MCK's Q1 results are expected to reflect strong prescription volume growth from GLP-1 demand, but lower margins may weigh on profitability.

https://www.zacks.com/stock/news/2666892/will-glp-1-demand-drive-mcks-top-line-this-earnings-season

$100 Invested In McKesson 5 Years Ago Would Be Worth This Much Today - McKesson ( NYSE:MCK )

McKesson MCK has outperformed the market over the past 5 years by 21.3% on an annualized basis producing an average annual return of 34.8%. Currently, McKesson has a market capitalization of $87.28 billion.

https://www.benzinga.com/insights/news/25/08/46812221/100-invested-in-mckesson-5-years-ago-would-be-worth-this-much-today

Unlocking Q1 Potential of McKesson ( MCK ) : Exploring Wall Street Estimates for Key Metrics

Evaluate the expected performance of McKesson (MCK) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

https://www.zacks.com/stock/news/2648842/unlocking-q1-potential-of-mckesson-mck-exploring-wall-street-estimates-for-key-metrics

Trending Today

Vaulta (prev.EOS) ($A) Crypto Forecast: Up 5.2% Today

XRP ($XRP) Crypto Forecast: Up 10.9% Today

Ethereum ($ETH) Crypto Forecast: Up 6.0% Today

Fortinet Inc. ($FTNT) Stock Forecast: Down 23.1% Today

ServiceNow Inc. ($NOW) Stock Forecast: Down 5.1% Today

Warner Bros. Discovery, Inc. ($WBD) Stock Forecast: Down 7.3% Today

Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Down 20.7% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Down 11.1% Today

Airbnb Inc. ($ABNB) Stock Forecast: Down 9.2% Today

New York Times Company (The) ($NYT) Stock Forecast: Down 5.2% Today

McKesson Corporation Price History

13.00.2025 - MCK Stock was up 1.3%

• The bullish movement in MCK likely stems from positive sentiment in the pharmaceutical sector, potentially fueled by robust earnings or promising drug advancements.
• This upward trend in MCK may also be buoyed by general market positivity, as evidenced by the strong performance of similar companies such as PDEX.
• Investors could be perceiving MCK as a secure investment option, resulting in heightened buying activity and an upward push in the stock price.

03.05.2025 - MCK Stock was down 1.2%

• The recent downtrend in McKesson's stock could be due to profit-taking by investors following an extended period of growth.
• Market movements may reflect wider economic uncertainties or specific challenges within the healthcare sector affecting the company's stock value.
• Investor decisions may be influenced by short-term market changes rather than the company's overall long-term success.
• Monitoring McKesson's response to the market decline and potential factors that could reverse this trend is important going forward.

14.00.2025 - MCK Stock was up 0.6%

• McKesson exhibited significant bullish momentum today, surpassing market benchmarks.
• The company has consistently outperformed the market, delivering an average yearly return of 16.04% over the past 15 years.
• McKesson's robust position in the healthcare field and its adeptness in responding to market dynamics likely underlie its strong performance.
• Investor optimism regarding McKesson's future growth potential appears to be driving the bullish stock movement.

07.07.2025 - MCK Stock was down 5.2%

• McKesson (MCK) exceeded Q1 earnings and revenue projections, displaying robust financial results.
• Despite increased prescription volume driven by GLP-1 demand, lower margins might have influenced profitability.
• The company has demonstrated consistent growth and a strong average annual return, outperforming the market in the last 5 years.
• Today, McKesson (MCK) faced a bearish trend, declining more than the broader market, potentially linked to profit-taking following recent positive developments and concerns about margin pressures impacting profitability.

07.07.2025 - MCK Stock was down 7.5%

• Q1 earnings surpassed expectations and the FY26 EPS outlook was raised, but McKesson's stock faced a downward trend.
• Investor concerns were influenced by a decreasing gross margin and uncertainties regarding the company's spin-off plans, contributing to the decline in stock value.
• Despite strong prescription volume growth driven by GLP-1 demand, it may not have fully countered the impact of reduced margins on overall profitability.
• The market reaction, including a sell-off, seemed to indicate that investors were anticipating even more robust performance from McKesson despite the positive earnings outcomes.

07.10.2024 - MCK Stock was up 12.4%

• Recent positive developments contributed to McKesson's stock rise:
• Increased options activity indicated investor optimism about the company's future.
• Analysts raised their forecasts post a favorable earnings report, emphasizing the company's strong financial results.
• McKesson exceeded Q2 earnings and revenue expectations, further boosting investor confidence.
• The company's long-term market outperformance, demonstrated by a significant return on investment spanning two decades, attracted more investors, leading to a rise in stock value.

07.10.2024 - MCK Stock was up 9.4%

• McKesson reported better-than-expected second-quarter financial results, with earnings of $7.07 per share and sales of $93.70 billion, beating analyst estimates. This positive earnings report likely contributed to the bullish movement.
• Analysts have turned bullish on McKesson, with upgrades and increased price targets following the upbeat earnings report. This positive sentiment from analysts could have further boosted the stock.
• The company's consistent outperformance over the past 20 years, with an average annual return of 15.46%, has likely attracted investors looking for long-term growth opportunities.
• Expectations for solid performance in the U.S. Pharmaceutical and Specialty Solutions segment in the upcoming earnings report may have also fueled investor optimism and contributed to the bullish movement in the stock.

07.10.2024 - MCK Stock was up 11.0%

• Today, McKesson's strong bullish movement is supported by several factors:
• Increased options activity and positive investor sentiment suggest confidence in the company's future.
• Second-quarter fiscal 2025 results surpassing expectations, especially in the U.S. Pharmaceutical segment, have contributed to a favorable market outlook.
• Analysts revising their forecasts upward and expressing optimism about McKesson post-earnings have further encouraged investor confidence.
• In conclusion, robust earnings performance and a positive outlook for McKesson have driven the stock's bullish trend today.

09.04.2025 - MCK Stock was down 2.6%

• Today's downward movement in MCK may be linked to profit-taking by investors following strong year-to-date gains.
• Despite surpassing Q4 earnings estimates and seeing optimistic options activity, concerns about future growth could have led to a sell-off.
• Broker opinions, which include a Buy rating but also express doubts about the effectiveness of such recommendations, might have contributed to investor hesitancy.
• The positive outlook for Q4 earnings reflecting the performance of the U.S. Pharmaceutical and Specialty Solutions segment may not have been sufficient to counter broader market sentiment or profit-taking activities.

06.01.2025 - MCK Stock was down 5.2%

• Following the release of its Q3 earnings report, McKesson's stock faced a downturn due to missing expectations and a decrease in gross margin, particularly in the Medical Surgical Solutions segment.
• The acquisition of PRISM Vision Holdings was viewed positively as a move to bolster McKesson's specialty care capabilities and leadership in eye health solutions. However, this development did not have an immediate impact on the stock price.
• Despite anticipated strong performance in the U.S. Pharmaceutical and Specialty Solutions segment, McKesson's stock performed worse than the overall market, reflecting investor apprehensions.
• The market response to McKesson's Q3 earnings indicates that investors may have been more focused on the lower sales and margin contraction in the Medical Surgical Solutions segment, overshadowing growth in other areas of the company.

02.03.2025 - MCK Stock was up 2.9%

• Insights from options trading predict a bearish outlook for MCK, contrasting the notable bullish movement seen in the stock. This discrepancy may indicate a difference in sentiment between institutional investors and the market as a whole.
• Despite favorable recommendations from financial experts to purchase MCK shares, the stock surged significantly. Potential factors contributing to this surge include positive earnings, new business agreements, or other favorable company-specific developments.
• MCK's stock price saw a +0.74% increase compared to the previous trading day, which could be influenced by broader market trends, sector performance, or macroeconomic conditions affecting the healthcare industry.
• It is advisable for investors to keep a close watch on MCK's options market and company-specific updates to accurately assess future market movements.

31.06.2025 - MCK Stock was down 2.9%

• Today's decline in McKesson's stock may be due to investor profit-taking following a recent period of optimism.
• Despite anticipated earnings growth and favorable analyst recommendations, various market dynamics and external influences might have contributed to the stock's downturn.
• Market volatility or broader economic uncertainties could have overshadowed the company's short-term growth outlook, prompting the bearish shift.
• It is advisable for investors to monitor developments within the healthcare sector and overall market conditions that could affect McKesson's stock performance in the immediate future.